查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1538233

中和抗体市场报告：2030 年趋势、预测和竞争分析

Neutralizing Antibody Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

中和抗体的趋势和预测

预计 2024 年至 2030 年，全球中和抗体市场将以 11.2% 的复合年增长率成长。这个市场的主要驱动力是类风湿性关节炎、多发性硬化症和狼疮等自体免疫疾病的盛行率不断上升，感染疾病率的上升，以及与传统疫苗和药物相比基于抗体的治疗的好处越来越多的人意识到。全球中和抗体市场前景广阔，医院/诊所、研究所、诊断实验室和製药市场充满机会。

按片段中和抗体

本研究按目标病毒、抗体类型、应用、最终用途和地区对全球中和抗体市场进行了预测。

中和抗体市场洞察

Lucintel 预测，在预测期内，治疗药物仍将是最大的细分市场。

在这个市场中，製药公司将继续成为最大的细分市场。

由于重要公司的存在以及全国范围内一致的医疗保健系统的建立，北美在预测期内将继续成为最大的地区。

常问问题

Q1.市场成长预测是多少：

A1. 2024年至2030年，全球中和抗体市场预计将以11.2%的复合年增长率成长。

Q2. 影响市场成长的关键驱动因素是：

A2. 这个市场的主要驱动因素是类风湿性关节炎、多发性硬化症和狼疮等自体免疫疾病的盛行率不断上升，感染疾病的盛行率不断上升，与传统疫苗和药物相比，人们越来越意识到抗体的好处。

Q3.市场的主要细分市场是：

A3. 全球中和抗体市场前景广阔，医院/诊所、研究所、诊断实验室和製药市场充满机会。

Q4.市场的主要企业是：

A4. 主要中和抗体公司如下：

  • Regeneron Pharmaceuticals
  • Eli Lilly and Company
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • Roche
  • Novartis
  • Merck
  • Pfizer
  • Johnson & Johnson

Q5.未来最大的细分市场是什么？

A5.Lucintel 预计治疗药物在预测期内仍将是其最大的细分市场。

Q6.未来五年预计哪些地区的市场成长最大？

A6. 由于重要公司的存在以及全国范围内一致的医疗保健系统的建立，预计北美在预测期内仍将是最大的地区。

Q7. 可以客製化报告吗？

A7。

目录

第一章执行摘要

第二章全球中和抗体市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球中和抗体市场趋势（2018-2023）和预测（2024-2030）
  • 按目标病毒分類的全球中和抗体市场
    • SARS-CoV-2
    • HIV
    • 流感
    • 伊波拉
    • 兹卡热
    • C型肝炎
  • 按抗体类型分類的全球中和抗体市场
    • 单株抗体
    • 多株抗体
  • 全球中和抗体市场（按应用）
    • 治疗
    • 诊断
    • 研究与开发
    • 其他的
  • 按最终用途分類的全球中和抗体市场
    • 医院/诊所
    • 研究所
    • 诊断实验室
    • 製药公司
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球中和抗体市场按地区划分
  • 北美中和抗体市场
  • 欧洲中和抗体市场
  • 亚太中和抗体市场
  • 中和其他地区的抗体市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
  • 全球中和抗体市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球中和抗体市场产能
    • 全球中和抗体市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Regeneron Pharmaceuticals
  • Eli Lilly and Company
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • Roche
  • Novartis
  • Merck
  • Pfizer
  • Johnson & Johnson
简介目录

Neutralizing Antibody Trends and Forecast

The future of the global neutralizing antibody market looks promising with opportunities in the hospital and clinic, research institute, diagnostic laboratory, and pharmaceutical company markets. The global neutralizing antibody market is expected to grow with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market are growing incidence of autoimmune disorders including rheumatoid arthritis, multiple sclerosis, and lupus, rising prevalence of infectious diseases, and increasing awareness of the benefits of antibody-based therapies compared to traditional vaccines and drugs.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Neutralizing Antibody by Segment

The study includes a forecast for the global neutralizing antibody by target virus, antibody type, application, end use, and region.

Neutralizing Antibody Market by Target Virus [Shipment Analysis by Value from 2018 to 2030]:

  • SARS-CoV-2
  • HIV
  • Influenza
  • Ebola
  • Zika
  • Hepatitis C

Neutralizing Antibody Market by Antibody Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monoclonal Antibodies
  • Polyclonal Antibodies

Neutralizing Antibody Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Therapeutics
  • Diagnostics
  • Research and Development
  • Others

Neutralizing Antibody Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Clinics
  • Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical Companies
  • Others

Neutralizing Antibody Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Neutralizing Antibody Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neutralizing antibody companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neutralizing antibody companies profiled in this report include-

  • Regeneron Pharmaceuticals
  • Eli Lilly and Company
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • Roche
  • Novartis
  • Merck
  • Pfizer
  • Johnson & Johnson

Neutralizing Antibody Market Insights

Lucintel forecasts that therapeutic will remain the largest segment over the forecast period.

Within this market, pharmaceutical company will remain the largest segment.

North America will remain the largest region over the forecast period due to the existence of important vital firms and a consistent healthcare system across the country.

Features of the Global Neutralizing Antibody Market

Market Size Estimates: Neutralizing antibody market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neutralizing antibody market size by target virus, antibody type, application, end use, and region in terms of value ($B).

Regional Analysis: Neutralizing antibody market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different target virus, antibody type, application, end use, and regions for the neutralizing antibody market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neutralizing antibody market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for neutralizing antibody market?

Answer: The global neutralizing antibody market is expected to grow with a CAGR of 11.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the neutralizing antibody market?

Answer: The major drivers for this market are growing incidence of autoimmune disorders including rheumatoid arthritis, multiple sclerosis, and lupus, rising prevalence of infectious diseases, and increasing awareness of the benefits of antibody-based therapies compared to traditional vaccines and drugs.

Q3. What are the major segments for neutralizing antibody market?

Answer: The future of the global neutralizing antibody market looks promising with opportunities in the hospital and clinic, research institute, diagnostic laboratory, and pharmaceutical company markets.

Q4. Who are the key neutralizing antibody market companies?

Answer: Some of the key neutralizing antibody companies are as follows:

  • Regeneron Pharmaceuticals
  • Eli Lilly and Company
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • Roche
  • Novartis
  • Merck
  • Pfizer
  • Johnson & Johnson

Q5. Which neutralizing antibody market segment will be the largest in future?

Answer: Lucintel forecasts that therapeutic will remain the largest segment over the forecast period.

Q6. In neutralizing antibody market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the existence of important vital firms and a consistent healthcare system across the country.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the neutralizing antibody market by target virus (SARS-CoV-2, HIV, influenza, Ebola, zika, and hepatitis C), antibody type (monoclonal antibodies and polyclonal antibodies), application (therapeutics, diagnostics, research and development, and others), end use (hospitals and clinics, research institutes, diagnostic laboratories, pharmaceutical companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Neutralizing Antibody Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Neutralizing Antibody Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Neutralizing Antibody Market by Target Virus
    • 3.3.1: SARS-CoV-2
    • 3.3.2: HIV
    • 3.3.3: Influenza
    • 3.3.4: Ebola
    • 3.3.5: Zika
    • 3.3.6: Hepatitis C
  • 3.4: Global Neutralizing Antibody Market by Antibody Type
    • 3.4.1: Monoclonal Antibodies
    • 3.4.2: Polyclonal Antibodies
  • 3.5: Global Neutralizing Antibody Market by Application
    • 3.5.1: Therapeutics
    • 3.5.2: Diagnostics
    • 3.5.3: Research and Development
    • 3.5.4: Others
  • 3.6: Global Neutralizing Antibody Market by End Use
    • 3.6.1: Hospitals and Clinics
    • 3.6.2: Research Institutes
    • 3.6.3: Diagnostic Laboratories
    • 3.6.4: Pharmaceutical Companies
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Neutralizing Antibody Market by Region
  • 4.2: North American Neutralizing Antibody Market
    • 4.2.1: North American Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
    • 4.2.2: North American Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
  • 4.3: European Neutralizing Antibody Market
    • 4.3.1: European Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
    • 4.3.2: European Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
  • 4.4: APAC Neutralizing Antibody Market
    • 4.4.1: APAC Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
    • 4.4.2: APAC Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
  • 4.5: ROW Neutralizing Antibody Market
    • 4.5.1: ROW Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
    • 4.5.2: ROW Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Neutralizing Antibody Market by Target Virus
    • 6.1.2: Growth Opportunities for the Global Neutralizing Antibody Market by Antibody Type
    • 6.1.3: Growth Opportunities for the Global Neutralizing Antibody Market by Application
    • 6.1.4: Growth Opportunities for the Global Neutralizing Antibody Market by End Use
    • 6.1.5: Growth Opportunities for the Global Neutralizing Antibody Market by Region
  • 6.2: Emerging Trends in the Global Neutralizing Antibody Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Neutralizing Antibody Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neutralizing Antibody Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Regeneron Pharmaceuticals
  • 7.2: Eli Lilly and Company
  • 7.3: AstraZeneca
  • 7.4: GlaxoSmithKline
  • 7.5: Sanofi
  • 7.6: Roche
  • 7.7: Novartis
  • 7.8: Merck
  • 7.9: Pfizer
  • 7.10: Johnson & Johnson